Mapping the current landscape of Klinefelter Syndrome registries: a scoping review Authors: Freya Stephenson, Anastasia Morris, Niran Arulkkumaran, Ann Lorenzo, Shreeya Mehta, Alice Cotton, Tet Yap Published: 2026 ABSTRACT Abstract AbstractObjectivesThis scoping review identifies existing registries collecting data on Klinefelter’s syndrome (KS) patients and what data are collected, with the purpose of identifying any KS-specific registries. Findings to be used to inform future registry development.DesignA comprehensive scoping review was conducted. Multiple sources were reviewed and articles screened based on inclusion criteria and exclusion criteria.Data sourcesSearches performed across multiple sources including PubMed, Embase, the Cochrane Library, WHO International Clinical Trials Registry Platform, Orphanet, EU Clinical Trials Register, King’s College London Library and charity organisation webpages.Eligibility criteriaThe included studies were required to focus on KS patients with reported data from an active registry that routinely collects data on KS patients.Data extraction and synthesisBasic information about registries identified in included articles was extracted. Registries identified were contacted with a standardised set of questions to collect additional contextual information. Findings are presented in tables.ResultsThe scoping review included 18 articles. From those, 10 registries storing KS patient data were identified. Only one of those registries was KS-specific. Only three out of 10 registries collected data that encompassed genetic, clinical and social variables. Most data included in registries were collected exclusively from medical records, although some registries included data from patient surveys. Registries that received government funding had more KS participants than those that did not.ConclusionsWith only one KS-specific registry existing worldwide and none within the UK, this review has identified a need for the development of further KS-specific registries. Data collected could be used to develop an accurate KS phenotype and therefore lead to increased diagnosis of the disorder, improving the lives of people with KS.Keywords: Male infertility, General endocrinology, GENETICS STRENGTHS AND LIMITATIONS OF THIS STUDY Additional contextual data retrieved from registry administrators allowed for a more indepth examination of the running of registries identified. Additional contextual data retrieved from registry administrators allowed for a more indepth examination of the running of registries identified. The screening process was strengthened by having four reviewers evaluate full-text articles and resolve all disagreements through team discussion, ensuring a consistent and reliable selection of studies. The screening process was strengthened by having four reviewers evaluate full-text articles and resolve all disagreements through team discussion, ensuring a consistent and reliable selection of studies. Not all active registries at the time of search may have had data published, this means not all databases collecting KS data may have been identified. Not all active registries at the time of search may have had data published, this means not all databases collecting KS data may have been identified. Not all identified registries responded to the request for further information; therefore, some data collection fields are not complete. Not all identified registries responded to the request for further information; therefore, some data collection fields are not complete. Search terms may not have captured all databases collecting data on KS patients, as all alternative names for registries were not included. Search terms may not have captured all databases collecting data on KS patients, as all alternative names for registries were not included. Background Klinefelter’s syndrome (KS) is a genetic disorder characterised by one or more extra X chromosomes.1 KS is caused by non-disjunction in maternal or paternal meiotic division.2 KS is a relatively common genetic disorder, with about 4800 people diagnosed in the UK.3 Phenotypically, KS presents with tall stature, small testes, gynaecomastia and infertility.4 However, this phenotype is variable and often inaccurate.5 Many with KS are not diagnosed until adulthood and it is thought around 50–75% with the condition go their whole lives without a diagnosis.6 Lack of knowledge regarding phenotype is a contributory factor to this statistic.5 Repercussions of late diagnosis include low self-esteem and poor mental health, people with KS often finding a diagnosis provides relief and an explanation for a life of unexplained symptoms.7 KS patients who receive diagnosis and therefore testosterone replacement therapy have been found to have reduced mortality.8 General practitioners have an important role in detection and referral of suspected KS as first point of care, improved understanding of KS presentation may improve rates of diagnosis.9 Patient registries are systems that collect and store data on a population over time.10 Registries can be useful in improving rare disease diagnosis by using the data collected to develop a more accurate phenotype. In rare diseases like KS, the small number of affected individuals and heterogeneity often limit the feasibility and statistical power of randomised controlled trials. Registries address this gap by collecting robust, uniform data across diverse populations and settings. This comprehensive dataset helps reduce variability, enables longitudinal studies and facilitates comparisons between treatments and outcomes.11 Registries also empower patient communities by involving them in data collection and research prioritisation. Setting up, managing and running a medical registry requires substantial effort from all stakeholders involved and therefore acts as a limitation of medical registries.11 It is not known what KS-specific registries exist or what data may be held in these registries. Therefore, a review of KS-specific registries is needed; a scoping review was the chosen method to do this as it provides an overview of available evidence irrespective of source.12 Aims This scoping review aims to identify any existing KS-specific registries and registries collecting data on KS patients; including what data are collected and where from (protocol included in online supplementary material 2). The development of a UK pilot KS registry is currently underway. It intends to collect data using patient surveys only.13 This review will provide insight into how KS is monitored currently and what can be learnt from what exists already to improve the development of KS databases, such as the UK pilot, in the future. In this review, the words ‘registry’ and ‘database’ will be used interchangeably. Methods A comprehensive search was conducted across multiple electronic databases and grey literature sources. Databases searched included PubMed, Embase and the Cochrane Library. Grey literature sources comprised the WHO International Clinical Trials Registry Platform, Orphanet, EU Clinical Trials Register and charity organisation webpages. Supplementary searches were conducted using the King’s College London Library search platform. Searches were limited to publications from January 2000 to the date searched (October 2024). The search terms used included “Klinefelter’s AND registry,” “Klinefelter’s AND database,” “47XXY AND registry” and “sex chromosome aneuploidy AND database.” The full search strategy is provided in the supplementary materials. Articles published in English and referenced active databases containing KS patient data were included. Duplicate records were removed before screening. Four reviewers independently screened titles and abstracts. Full-text articles were assessed against inclusion and exclusion criteria. Any disagreements were resolved by consensus. One study was excluded following further investigation due to lack of verifiable registry information. Data extraction included registry name, article details, data fields collected, managing institutions, staffing, software used and funding sources. Registry administrators were contacted with a standardised set of questions for additional information (see figure 1). Set of questions emailed to all registries identified. Inclusion criteria Articles focusing on KS patients. Articles focusing on KS patients. Articles reporting data from a database that stores data on KS patients. Articles reporting data from a database that stores data on KS patients. Articles published in English. Articles published in English. Exclusion criteria Articles reporting data from a database that is not currently active. Articles reporting data from a database that is not currently active. Articles where full text was not available. Articles where full text was not available. Not in English. Not in English. From the articles included, the following data were extracted: title, author, registry used, institutions involved in registry and types of data collected from registries. As some data were not available on extraction, identified registries were contacted via email with identical question sets (see figure 1) to clarify data and gain further insight into the structure of each database (all email responses are included in online supplementary material 1). Critical appraisal of papers was not considered as this scoping review aims to provide an overview of available evidence and draws no conclusions from the articles themselves. Patient involvement Patients and the public were not directly involved in the design or conduct of this scoping review. However, the research team engaged with the KS community through two clinical site visits to the Guy’s and St Thomas’ NHS Foundation Trust Adult Klinefelter Syndrome Clinic. During these visits, researchers conducted informal interviews with patients to explore their perspectives on registry development. While these data are not formally reported in this review, the insights gained regarding patient priorities for data collection and the necessity of a registry specific to KS patients provided essential context for the review’s objectives. Results After excluding duplicates, the initial search identified 1369 articles. Titles and abstracts were screened, and 60 articles were selected. Full texts were assessed against the inclusion and exclusion criteria, and 18 articles were included, see Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram (figure 2). All studies identified were conducted in Europe or North America. Over half of the studies included were observational; either cohort, case-control or register studies. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. KS, Klinefelter’s syndrome. Of those 18 articles, 10 registries storing data on KS patients were identified. Only one of the 10 registries identified was KS patient specific, the Klinefelter ItaliaN Group (KING) database. All others were either genetic disease registries or whole population patient registries. Table 1 features the databases identified, the articles from which they were identified and data from the registries that was reported in the articles14,31. Tables2 3 include the data retrieved from supplementary data collection via email responses, seven out of ten registries responded and all registries have been included in the tables32,38. Table 2 features information about how databases collect data and which KS variables are measured. Table 3 contains data about how the databases are maintained, including funding and staff. Table 1Table of data extracted from articles included in the reviewDatabase included in article/sTitles of article/sInstitutions involved in registryData collected from registry?KS specificPfizer International Growth Study (KIGS) databaseGrowth hormone deficiency and central precocious puberty in Klinefelter syndrome: report of a case and review of KIGS database14Not mentionedKaryotype, results of growth hormone stimulation tests, growth hormone dose prescribed, height, weight, ageNoCerner Health Facts databaseMetabolic Effects of Androgen-associated Body Mass in Klinefelter Syndrome15698 USA hospitals that employ the Cerner systemAndrogen replacement status, metabolic profile, age, height, weight, race/ethnicity, blood pressureNoKlinefelter ItaliaN Group (KING) databaseFirst baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy16SIAMS (Italian Society of Andrology and Sexuality Medicine) referral centresAge of diagnosis, testicular size, height, weight, waist circumference, metabolic profile, blood pressure, follicle stimulating hormone (FSH), luteinising hormone (LH), testosterone, smoking status, geographic location of KS patient, karyotype (non-mosaic)YesTriNetXTestosterone Therapy in Men with Klinefelter Syndrome: Analysis of a Global Federated Research Network17Multicentre (institutions not mentioned)KS diagnosis, testosterone level, intellectual disability, type 2 diabetes mellitus, obesity, hyperlipidaemia, hypertension, osteoporosis, pulmonary embolism, vascular thrombotic events, testosterone replacement therapy prescription, race, ageNoEUROCAT databaseContribution of ultrasonographic examination to the prenatal detection of chromosomal abnormalities in 19 centres across Europe1819 registries of congenital malformations from 11 European countries collaboratedPrenatal ultrasound results (including nuchal thickness), termination of pregnancy, stillbirth/live birth, chromosome abnormalities (including KS) diagnosed in the first 7 days of lifeNoDanish National Patient RegistryKlinefelter syndrome and testosterone treatment: a national cohort study on thrombosis risk19Not mentionedKS diagnosis, hospital discharges, karyotype, prescriptions, thromboembolism, prescription medications, testosterone, KS diagnosis, LH, haemoglobin, haematocritNoDanish National Patient RegistryComorbidity landscape of the Danish patient population affected by chromosome abnormalities20Not mentionedChromosome abnormalities (including KS), mosaic or non-mosaic karyotype, age, age at diagnosis, age at death, comorbiditiesNoDanish National Patient RegistryKlinefelter syndrome comorbidities linked to increased X chromosome gene dosage and altered protein interactome activity21Not mentionedKS diagnosis, testicular dysfunction, osteoporosis, gynaecomastia, intellectual disability, diabetes mellitus, undescended testicles, obesity, epilepsy, pituitary disorders, dental abnormalitiesNoGALAXY databaseResearch Priorities of Individuals and Families with Sex Chromosome Aneuploidies22Not mentionedAge, race, insurance status, KS diagnosisNoSwedish national patient registerHypogonadotropic hypogonadism, delayed puberty and risk for neurodevelopmental disorders23Not mentionedDiagnosis of delayed puberty, LH, FSH, diagnosis of autism, diagnosis of Attention Deficit Hyperactivity Disorder, diagnosis of intellectual disabilitiesNoSwedish national patient registerRisk of solid tumours and haematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort study24Not mentionedKS diagnosis, cancer diagnosisNoDanish Cytogenetic Central RegistryMorbidity in Klinefelter Syndrome: A Danish Register Study Based on Hospital Discharge Diagnoses25Data from seven laboratories performing postnatal karyotyping (five of which also perform prenatal testing)KS diagnosis, karyotype, date of diagnosis, method of diagnosisNoDanish Cytogenetic Central RegistryPrenatal and Postnatal Prevalence of Klinefelter Syndrome: A National Registry Study26Data from seven laboratories performing postnatal karyotyping (five of which also perform prenatal testing)Maternal age, KS diagnosis (prenatal or postnatal), year of diagnosis, mosaic or non-mosaic KSNoDanish Cytogenetic Central RegistrySocioeconomic Trajectories Affect Mortality in Klinefelter Syndrome27Data from seven laboratories performing postnatal karyotyping (five of which also perform prenatal testing)Mosaic or non-mosaic KS, outcome of pregnancyNoDanish Cytogenetic Central RegistryIncreased Mortality in Klinefelter Syndrome28Data from seven laboratories performing postnatal karyotyping (five of which also perform prenatal testing)KS diagnosis, karyotype, date of diagnosis, method of diagnosisNoDanish Cytogenetic Central RegistrySocio-economic factors affect mortality in 47,XYY syndrome - A comparison with the background population and Klinefelter syndrome29Data from seven laboratories performing postnatal karyotyping (five of which also perform prenatal testing)Maternal age, KS diagnosis (prenatal or postnatal), year of diagnosis, mosaic or non-mosaic KSNoDanish Cytogenetic Central RegistryCancer incidence in men with Klinefelter syndrome30Data from seven laboratories performing postnatal karyotyping (five of which also perform prenatal testing)Mosaic or non-mosaic KS, outcome of pregnancyNoPEDSnetPopulation-based Assessment of Cardiometabolic-related Diagnoses in Youth with Klinefelter Syndrome: A PEDSnet Study31Six paediatric institutions in the USAKS diagnosis, age, race/ethnicity, insurance status, site of care, duration of care, obesity, metabolic profiles, blood pressure, liver function tests, liver dysfunction diagnosisNoKS, Klinefelter syndrome. Table of data extracted from articles included in the review KS, Klinefelter syndrome. Table 2Table of data collected from email responses about variables measured by databasesDatabaseInstitutions/hospitals involvedHow are data collected?Variables measuredNumber of KS patientsDiagnosis of KS patients in databaseEUROCAT32UnknownUnknownPlace of birthPrenatal diagnostic techniquesPrevious pregnanciesMaternal ageMaternal diseaseMaternal alcohol useMaternal smokingMaternal medicationMaternal occupationAge of father at deliveryType of birthUnknownKaryotypingGALAXY33Children’s Hospital ColoradoLurie Children’s Hospital of Chicago Nemours Children’s HealthcarePatient surveysMedical recordsGenetic testingMedicationHospital admissions/dischargeLaboratory resultsRaceInsurance statusSocial determinants of health230Karyotyping (mosaic and non-mosaic) Microarray Fluorescence in situ hybridisation (FISH)Klinefelter ItaliaN Group database34Italian Society of Andrology and Sexual Medicine (SIAMS) referral centre across ItalyMedical recordsDemographical dataHormonal and biochemical dataHospital stays609KaryotypingPEDSnet35Children’s national hospital Children’s hospital of Philadelphia Cincinnati children’s hospital medical centre Riley’s children’s health Nationwide children’s hospital Nemours children’s health Seattle children’s hospital Stanford children’s health Texas Children’s hospitalMedical chart reviewNatural language processing of medical notesPatient-reported outcomes/quality of life survey questionsDemographic dataDiagnoses (karyotype)MedicationsLaboratory resultsMedical proceduresMedical visits (outpatient and inpatient) Healthcare providersSocial determinants of healthOver 3000Karyotyping If diagnosed outside of the PEDSnet institution method not recordedSwedish National Database36All hospitals and specialised outpatient care centres (primary care not recorded)Medical recordsPersonal registration numberGenderAgePlace of residenceDates of admission/dischargeDetails of admission/dischargeDiagnosesProcedures886UnknownDanish cytogenetic Register37Genetic departments in Copenhagen: Rigs Hospitalet Hvidovre Hospital Kennedy Institute Odense University Hospital Vejle Hospital Århus University Hospital Ålborg University Hospital.Raw data from genetic analysisPostnatal tests (eg, blood samples) prenatal tests (chorionic villous sampling, amniotic fluid and Non-invasive pre-natal blood test) abortion tissue results~1400Karyotyping (mosaic and non-mosaic) Array CGHDanish National Patient Registry38All public and most private hospitals and clinics in DenmarkElectronic health records (EHR) SE12 service (an EHR)TreatmentInvestigationsProceduresAdmissions/appointmentsUnknownUnknownTriNetXNo response (NR)NRNRNRNRCerner health factsNRNRNRNRNRPfizer international growth study databaseNRNRNRNRNRKS, Klinefelter syndrome. Table of data collected from email responses about variables measured by databases KS, Klinefelter syndrome. Table 3Table of data collected from email responses about maintaining and funding databasesDatabaseWho maintains the database?Software usedFundingEUROCAT32UnknownUnknownEuropean UnionGALAXY33Principal Investigator Program manager Regulatory coordinator Research coordinatorsREDCapSeed funding from the Association for X and Y Chromosome Variations Investigators university funds.Klinefelter ItaliaN Group database34EndocrinologistsUnknownNo funding requiredPEDSnet35Clinicians Computer engineerPostgreSQLThe Patient Centered Outcomes Research Institute Federal grants Private foundations Industry companiesSwedish National Database36Six full-time employees (including computer engineer)SASSwedish governmentDanish cytogenetic Register37Local data managers Part-time employee with data and programming skills Advisory board of medical specialists Representatives from each genetic departmentMicrosoft SQL database BI-software SASGenetic departments involved finance the registryDanish National Patient Registry38System administrator Database management Data inputters CliniciansIBM Db2 SQ1TriNetXNo response (NR)NRNRCerner health factsNRNRNRPfizer international growth study databaseNRNRNR Table of data collected from email responses about maintaining and funding databases How is KS diagnosed across databases? Across the databases identified in this review, diagnosis by karyotyping was the most popular method. If other methods were used, it was either Array CGH/Microarray or fluorescence in situ hybridisation.33 37 Collecting data from KS patients in a population Registries that received government funding had more KS participants than those that did not. PEDSnet (>3000 participants in registry), the Danish cytogenetic register (~1400 participants in registry) and the Swedish National database (886 participants in registry) contained the most KS patients compared with other registries; all three of these databases received government funding.35,37 The KING database and the Cerner Health Facts database only collected data on KS patients that were treated in centres that were affiliated with their system (Italian Society of Andrology and Sexual Medicine (SIAMS) centres and the Cerner system, respectively).15 34 The Danish Cytogenetic register was the only database not collecting data from medical records, instead retrieving raw data from genetic analysis.37 The KING Database, the Swedish National Database and the Danish Patient register collected data from medical records alone,34 38 while GALAXY and PEDSnet employed other methods in conjunction with medical records.33 35 However, GALAXY included data retrieved from patient surveys, which were used to collect information on social determinants of health and enabled patients to upload copies of genetic tests that were missing from medical records.33 Alongside medical records, PEDSnet uses a natural language processing tool to retrieve procedure results from unstructured medical notes as well as patient surveys to collect data about quality of life and patient-reported outcomes.35 Types of variables being collected by databases All databases collected data on one or more of the following health categories: genetic, clinical or social. Genetic data included variables such as karyotyping, chorionic villous sampling and Non invasive pre-natal testing. Clinical data included testosterone levels, metabolic profiles and prescriptions. Examples of social data included ethnicity and occupation. Although the Danish registries did not individually capture data on all domains, cross-database linkage is possible via patient identification numbers. This allows data across all national Danish registries to be accessed and combined.39 The KING database The KING database, in Italy, was the only registry identified in this review that is specific to KS alone. It is run by endocrinologists.16 34 The registry collects information on 609 KS patients as of October 2024, although further recruitment is underway.34 The KING database collects information on KS patients from Northern, Central and Southern Italy by recruiting from SIAMS centres across the country.16 As the KING database is specific to patients with KS, data are collected that is relevant to its manifestations, including testicular size, metabolic profile, follicle stimulating hormone, luteinising hormone and total testosterone.16 Discussion This review is the first to investigate the existence of KS-specific registries and has highlighted the need for development of further registries of this type. It has been found there is currently only one KS-specific database in existence worldwide. It is unknown whether the search terms in this review were broad enough to encompass all databases collecting data on KS patients. Search terms of either ‘registry’ or ‘database’ exclude articles that did not refer to databases using these terms; therefore, the review may not be representative. However, comprehensive databases were searched to increase the chances of identifying KS-specific registries. Some registries did not reply to requests for supplementary data extraction; thus, data collected are incomplete and important key aspects may have been missed from our analysis; however, the registries were still included in the results tables for transparency. The final limitation to consider pertains to registries that responded to further questions. Databases did not always provide answers to all questions and in some cases the questions were misinterpreted. Consequently, the data extracted may not be representative. For example, the question, ‘Is there a team running the database?’ (figure 2), is a closed question. However, the reviewers intended the response to be open and to include number of employees. As a result, data collected from email responses was often non-specific. This review found that databases that received government funding had more participants; however, this could be reflective of differences in population size. Alternatively, this could indicate that government funding may improve successful long-term operation of KS-specific registries. However, the UK operates a public health service which means funding is distributed using a utilitarian approach where common diseases are prioritised.40 As KS is a rare genetic disorder considering alternative sources of funding for the pilot UK KS registry13 may be necessary. Results showed some registries collected data using a single electronic health system that is used across multiple centres, improving ease of data collection. This is only possible if multiple centres employ the same electronic health system. Cross registry linkage, as seen in Denmark, offers another method to achieve broad retrieval. However, in the UK, where electronic health records are fragmented and patient data are not available across trusts, a KS-specific registry collecting data on all KS outcomes may bypass barriers such as confidentiality and problems with data sharing. In addition to this, the UK pilot KS registry13 intends to use patient surveys exclusively to circumvent data sharing difficulties. However, this review found medical records were used almost exclusively as they allow access to a wide range of patient information over time41, and in the case of the GALAXY database, patient surveys have been used only for completeness. The KING database was the only KS-specific registry found in this review; it is run by endocrinologists which is advantageous as they are often one of the main points of care for those with KS. However, due to the exclusions of other medical specialists relevant to those with KS not all variables are measured in this database. Clinical results pertinent to known complications such as osteoporosis, learning difficulties and breast cancer would be useful additions to ensure data collected encompasses the full breadth of KS patients’ health outcomes. 42 These variables should be included when developing further KS registries in order to fully understand this condition. An ideal KS registry would involve input from all specialties involved in KS patient care. It would also collect genetic information, monitor clinical parameters and measure social factors in order to create a holistic picture of KS. It would also either receive consistent funding or incur little cost to remain sustainable over a long period of time. The UK pilot KS-specific database aims to adopt a multidisciplinary approach not yet seen in a KS-specific registry. This database will receive input from specialties including endocrinology, urology, genetics, fertility medicine, psychiatry, psychosexual medicine, neurodisability, plastic surgery and dentistry. This approach enables the analysis of a broad range of KS-specific outcomes, including osteoporosis, infertility, learning difficulties and dental decay. To ensure large-scale data capture this registry must use a platform capable of aggregating information across multiple electronic patient record systems. Future work should focus on formulating broad domains of data collection and a core set of KS-specific variables. These could be informed by existing clinical guidelines and consensus frameworks to support standardisation and comparability across settings. Conclusion There is a clear lack of KS-specific registries globally, with only one dedicated database currently identified. An ideal UK KS registry would include a multidisciplinary approach with data collection that is not impacted by fragmentation of electronic health records. The ongoing development of the pilot KS-specific database in the UK13 could help develop a more accurate KS phenotype due to the involvement of all healthcare specialties associated with KS. This could improve rates of detection, diagnosis and treatment guidelines. Supplementary material Footnotes Funding: Open access publication of this article was supported by the King's College London MBBS Programme Open Access Publishing Fund. Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2025-107451). Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Ethics approval: Not applicable. Collaborators: Not applicable. Patient and public involvement: Patients and/or the public were not involved in the design or conduct or reporting or dissemination plans of this research. Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information. References Supplementary Materials Data Availability Statement All data relevant to the study are included in the article or uploaded as supplementary information.